INCY Incyte Corp.

NASDAQ
$121.47

Incyte Corp. (INCY) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with INCY's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
10
48 transactions
Purchases
$0
0 shares
Sales
$55.6M
523,966 shares
Net activity
-$55.6M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $55.6M 48 transactions · 523,966 shares

Largest single sale: $19.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
CAGNONI PABLO J President, Global Head of R&D Sell 10,801 $125.56 $1.4M 183,200 −5.6% of holding
CAGNONI PABLO J President, Global Head of R&D Sell 10,803 $120.04 $1.3M 194,001 −5.3% of holding
CAGNONI PABLO J President, Global Head of R&D Sell 10,640 $122.69 $1.3M 204,804 −4.9% of holding
Mayes Patrick A EVP & Chief Scientific Officer Sell 2,207 $123.99 $273.6K 61,441 −3.5% of holding
Mayes Patrick A EVP & Chief Scientific Officer Sell 6,055 $120.43 $729.2K 61,441 −9% of holding
Mayes Patrick A 11 fills EVP & Chief Scientific Officer Sell 41,899 $119.46 $5.0M 88,679 −32.1% of holding
CAGNONI PABLO J President, Global Head of R&D Sell 15,888 $119.70 $1.9M 215,444 −6.9% of holding
Stein Steven H CMO & Head of Late-Stage Dev. Sell 1,877 $114.73 $215.3K 21,118 −8.2% of holding
Issa Mohamed Khairie EVP, Head of U.S. Commercial Sell 1,093 $115.01 $125.7K 63,940 −1.7% of holding
Stein Steven H CMO & Head of Late-Stage Dev. Sell 28,237 $113.05 $3.2M 26,083 −52% of holding
Tray Thomas Principal Accounting Officer Sell 2,639 $100.00 $263.9K 21,132 −11.1% of holding
Tray Thomas Principal Accounting Officer Sell 2,051 $97.35 $199.7K 21,132 −8.8% of holding
Clancy Paul J Director Sell 15,000 $94.93 $1.4M 23,741 −38.7% of holding
CAGNONI PABLO J President, Global Head of R&D Sell 18,667 $96.50 $1.8M 262,692 −6.6% of holding
CAGNONI PABLO J President, R&D Sell 18,667 $94.24 $1.8M 234,800 −7.4% of holding
CAGNONI PABLO J President, R&D Sell 18,668 $100.91 $1.9M 234,800 −7.4% of holding
Issa Mohamed Khairie EVP, Head of US Oncology Sell 10,856 $109.07 $1.2M 66,132 −14.1% of holding
Stein Steven H EVP & Chief Medical Officer Sell 15,634 $101.70 $1.6M 34,203 −31.4% of holding
Tray Thomas Principal Accounting Officer Sell 2,774 $100.00 $277.4K 22,973 −10.8% of holding
Tray Thomas Principal Accounting Officer Sell 600 $98.25 $59.0K 22,973 −2.5% of holding
Morrissey Michael James EVP, Head of Tech. Operations Sell 4,323 $97.26 $420.5K 27,507 −13.6% of holding
Morrissey Michael James 2 fills EVP, Head of Tech. Operations Sell 54,008 $97.29 $5.3M 85,005 −38.9% of holding
Mayes Patrick A EVP & Chief Scientific Officer Sell 255 $94.94 $24.2K 60,011 −0.4% of holding
Mayes Patrick A EVP & Chief Scientific Officer Sell 5,553 $95.58 $530.8K 60,266 −8.4% of holding
Stein Steven H EVP & Chief Medical Officer Sell 20,105 $102.51 $2.1M 63,129 −24.2% of holding
Stein Steven H EVP & Chief Medical Officer Sell 2,559 $102.96 $263.5K 100,327 −2.5% of holding
Tray Thomas Principal Accounting Officer Sell 600 $103.00 $61.8K 23,573 −2.5% of holding
Tray Thomas Principal Accounting Officer Sell 169 $102.00 $17.2K 24,173 −0.7% of holding
Denton Sheila A. EVP & General Counsel Sell 278 $104.36 $29.0K 26,569 −1% of holding
Hoppenot Herve Director Sell 187,500 $105.46 $19.8M 329,646 −36.3% of holding
Stein Steven H EVP & Chief Medical Officer Sell 5,233 $102.20 $534.8K 102,886 −4.8% of holding
Denton Sheila A. EVP & General Counsel Sell 598 $101.36 $60.6K 26,569 −2.2% of holding
Heeson Lee EVP, Head of Incyte Intl Sell 3,074 $94.02 $289.0K 29,241 −9.5% of holding
Denton Sheila A. EVP & General Counsel Sell 277 $85.13 $23.6K 26,569 −1% of holding
Denton Sheila A. EVP & General Counsel Sell 3,501 $85.54 $299.5K 26,569 −11.6% of holding
Denton Sheila A. EVP & General Counsel Sell 599 $87.65 $52.5K 33,200 −1.8% of holding
Denton Sheila A. EVP & General Counsel Sell 278 $83.15 $23.1K 33,200 −0.8% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.